Author

C. Eslinger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Farooqi· 1 shared A. Hindle· 1 shared A. Smith· 1 shared B. Koneru· 1 shared C. P. Reynolds· 1 shared E. Cadogan· 1 shared J. Wilson· 1 shared M. R. Makena· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Farooqi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ALT Neuroblastoma Chemoresistance due to ATM Activation by Telomere Dysfunction is Reversible with the ATM Inhibitor AZD0156

B. Koneru, A. Farooqi, T. H. Nguyen, W. H. Chen, A. Hindle, C. Eslinger, M. R. Makena, T. A. Burrow, J. Wilson, A. Smith, V. P. Reddy, E. Cadogan, S. T. Durant, C. P. Reynolds

This study shows that ATM activation due to telomere dysfunction causes chemoresistance in ALT neuroblastoma, which can be reversed by the ATM inhibitor AZD0156.

bioRxiv · Apr 6, 2021Cancer Biology